These Analysts Boost Their Forecasts On UiPath After Upbeat Q1 Results

UiPath (PATH) reported Q1 earnings of 11 cents per share on revenue of $356.62 million, exceeding analyst estimates of 10 cents and $332.87 million, respectively. The company raised its FY26 revenue guidance to $1.549-$1.554 billion, surpassing the previous estimate of $1.52-$1.53 billion and the consensus of $1.53 billion. Following the earnings release, multiple analysts raised their price targets on UiPath, though most maintained neutral ratings.

Analysis

UiPath Inc. (PATH) delivered better-than-anticipated first-quarter financial results, with earnings of 11 cents per share surpassing the 10-cent analyst consensus, and quarterly sales of $356.62 million exceeding the estimated $332.87 million. CEO Daniel Dines characterized this as a "milestone quarter," driven by the launch of UiPath's agentic automation platform, a development perceived as a significant step in its product evolution and a key component of enterprise automation. In line with this positive momentum, the company increased its fiscal 2026 revenue guidance to $1.549-$1.554 billion, from a prior $1.52-$1.53 billion and above the $1.53 billion consensus, while also projecting second-quarter revenue of $345-$350 million, ahead of the $333.12 million estimate. Despite these strong indicators and an overall strongly positive sentiment signal (0.75), UiPath shares experienced a minimal 0.3% increase to $12.98. While analysts from firms such as Wells Fargo, RBC Capital, and Barclays raised their price targets, their ratings predominantly remained neutral (e.g., Equal-Weight, Sector Perform, Neutral), suggesting that while the operational performance is acknowledged, broader conviction for significant upside may be tempered or that potential risks are still being weighed.

Key Decisions for Investors

• Investors should carefully evaluate the divergence between UiPath's robust Q1 earnings, enhanced FY26 guidance, and the subdued stock reaction, alongside the consistently neutral stance from analysts despite upward revisions to price targets.
• The market adoption and impact of the newly launched agentic automation platform represent a key catalyst to monitor, which could dictate whether UiPath can outperform the current cautious market sentiment.
• Consider the current valuation relative to the improved financial outlook and the potential long-term growth driven by its new AI-powered automation capabilities, weighing if the current price adequately reflects these prospects or if persistent concerns cap near-term appreciation.